spacer
home > ict > spring 2016 > across the globe
PUBLICATIONS
International Clinical Trials

Across the Globe

The purpose of clinical trials is, simply put, to evaluate the effects of a drug on trial participants. It makes sense to involve participants from as many ethnic groups as possible, in order to assess the drug’s efficacy and announce it as safe for the public to use.

However, despite continuous efforts to globalise these trials, developing countries are still under-represented in clinical research – and there are a number of factors contributing to this siuation, like the lack of commercial viability and trained researchers, for example (1). Why is this contradictory? For one, the sheer population numbers in these countries means that there is a bigger patient pool available than in developed countries; furthermore, these potential patients might also be more willing to participate in a trial, and – in what is perhaps the most significant benefit of carrying out trials in remote locations – they can be recruited at substantially less cost compared to more affluent countries, as well as at a much faster rate (2).

References
1. Visit: www.journals.plos.org/plosmedicine/article?id=10.1371/ journal.pmed.1001228
2. Visit: www.fda.gov/downloads/training/ clinicalinvestigatortrainingcourse/ucm378499.pdf

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer

Print this page
Send to a friend
Privacy statement
News and Press Releases

AffyXell Expands its Strategic Partnership with GenScript ProBio

London and Wetherby, UK, 16 May 2022: Avacta Group plc (AIM: AVCT), a clinical stage oncology drug company developing innovative cancer therapies and powerful diagnostics based on its proprietary pre|CISION™ and Affimer® platforms, is pleased to announce that AffyXell, its joint venture with South Korean drug maker Daewoong Pharmaceutical, has expanded its strategic partnership with GenScript ProBio, a leading biopharmaceutical manufacturer.
More info >>

White Papers

Overcoming research challenges with Adaptive Trials

PCI Pharma Services

There has been cause for concern within the pharmaceutical industry over the last five years, regarding increasing research and development costs, combined with a fall in the number of new drugs brought to market. In an attempt to overcome this issue there has been a significant rise in the use of adaptive clinical trial designs, whilst saving time and money as well as facilitating more effective decision making. One of the biggest challenges that pharmaceutical companies have experienced has been delivering compliant clinical trials supplies across diverse patient populations in the relatively short timeframes that adaptive trial designs require, remaining focused on ensuring that patient compliance and product quality is in no way compromised. This demand has led to the launch of fast response services that support Research and Development in responding to changing dosing regimens mid-trial.
More info >>

 

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement